Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person3
Evogene Ltd.
Company
Genie Energy Ltd.
Company
Everon UK Ltd
Company · 06955874
Primary record15
Evogene Ltd. filed SCHEDULE 13D/A
on October 6, 2026. Y Kfir Silberman b AF N L3 0.00 3057488.00 2557488.00 0.00 3057488.00 N 16.94 IN (1) The securities reported on this Schedule are held by L.I.A. Pure Capital Ltd. ("Pure Capital"). Kfir Silberman is t
Evogene Ltd. filed 4
SEC form 4 filed by Evogene Ltd. (CIK 1574565) on 2026-09-30.
Evogene Ltd. filed 4
SEC form 4 filed by Evogene Ltd. (CIK 1574565) on 2026-09-30.
Evogene Ltd. filed 4
SEC form 4 filed by Evogene Ltd. (CIK 1574565) on 2026-09-30.
Evogene Ltd. filed 4
SEC form 4 filed by Evogene Ltd. (CIK 1574565) on 2026-09-30.
Evogene Ltd. filed SCHEDULE 13D/A
on July 31, 2026. Y Kfir Silberman b AF N L3 0.00 3057488.00 2557488.00 0.00 3057488.00 N 19.35 IN (1) The securities reported on this Schedule are held by L.I.A. Pure Capital Ltd. ("Pure Capital"). Kfir Silberman is the
Evogene Ltd. filed SCHEDULE 13D/A
on July 31, 2026. The aggregate beneficial ownership includes 10,950 Ordinary Shares underlying share options held by the Reporting Person that are currently exercisable or exercisable within 60 days of August 11, 2026.
Evogene Ltd. filed SCHEDULE 13D/A
on July 31, 2026. Y Kfir Silberman b AF N L3 0.00 3057488.00 2557488.00 0.00 3057488.00 N 19.35 IN (1) The securities reported on this Schedule are held by L.I.A. Pure Capital Ltd. ("Pure Capital"). Kfir Silberman is the
Evogene Ltd. filed 4
SEC form 4 filed by Evogene Ltd. (CIK 1574565) on 2026-08-26.
ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A
0001172661-26-003576.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001172661-26-002145 0001601086 XXXXXXXX LIVE 1 Ordinary shares, par value NIS 0.2 per share 06/30/2026 0001574565 EVOGENE LTD. M4
Evogene Ltd. filed SCHEDULE 13D/A
on July 31, 2026. The aggregate beneficial ownership includes 10,950 Ordinary Shares underlying share options held by the Reporting Person that are currently exercisable or exercisable within 60 days of August 11, 2026.
Evogene Ltd. filed SCHEDULE 13D/A
on July 31, 2026. 0001626639 N Kfir Silberman b AF N L3 0.00 3057488.00 2557488.00 0.00 3057488.00 N 19.35 IN (1) The securities reported on this Schedule are held by L.I.A. Pure Capital Ltd. ("Pure Capital"). Kfir Silbe
Evogene Ltd. filed 4
SEC form 4 filed by Evogene Ltd. (CIK 1574565) on 2026-08-13.
Evogene Ltd. filed SCHEDULE 13D
on July 31, 2026. The aggregate beneficial ownership includes 10,950 Ordinary Shares underlying share options held by the Reporting Person that are currently exercisable or exercisable within 60 days of August 4, 2026. O
Evogene Ltd. filed SCHEDULE 13D/A
on July 31, 2026. Y Kfir Silberman b AF N L3 0.00 2524400.00 2024400.00 0.00 2524400.00 N 15.98 IN (1) The securities reported on this Schedule are held by L.I.A. Pure Capital Ltd. ("Pure Capital"). Kfir Silberman is the